MARKET WEIGHTON GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: B81009 | YORK, YO43 3FF
Showing results 101-150 of 639
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Candesartan cilexetil | 492 | 15.8K | £866 | -58.5% ▼ |
| Spironolactone | 487 | 14.7K | £2.4K | -9.7% ▼ |
| Buprenorphine | 484 | 2,022 | £9.8K | +32.1% ▲ |
| Nitrofurantoin | 481 | 8,189 | £5.7K | +0.8% vs avg |
| Melatonin | 479 | 34.5K | £9.6K | +44.0% ▲ |
| 479 | 85.6K | £3.1K | +1.0% vs avg | |
| Flucloxacillin sodium | 477 | 25.7K | £1.3K | +6.1% ▲ |
| Eplerenone | 470 | 13.4K | £1.7K | +77.2% ▲ |
| Hydrocortisone | 469 | 12.6K | £1.8K | +4.6% ▲ |
| Senna | 456 | 25.3K | £681 | -24.2% ▼ |
| Insulin aspart | 455 | 3,106 | £18.9K | +19.5% ▲ |
| Quinine sulfate | 411 | 11.4K | £2.0K | +42.0% ▲ |
| Carbocisteine | 406 | 48.2K | £2.6K | -24.0% ▼ |
| Famotidine | 403 | 14.1K | £8.3K | -17.4% ▼ |
| Carbamazepine | 397 | 32.4K | £2.1K | +33.8% ▲ |
| Lacidipine | 395 | 10.6K | £888 | +230.6% ▲ |
| Doxycycline hyclate | 390 | 3,955 | £382 | -23.9% ▼ |
| Promethazine hydrochloride | 385 | 14.6K | £1.9K | +7.7% ▲ |
| Fluticasone furoate | 384 | 395 | £2.8K | +98.2% ▲ |
| Mometasone furoate | 377 | 401 | £3.1K | -6.1% ▼ |
| 377 | 698 | £797 | +71.1% ▲ | |
| Loperamide hydrochloride | 375 | 38.8K | £3.3K | +61.0% ▲ |
| Methotrexate | 371 | 7,336 | £7.7K | +14.0% ▲ |
| Olmesartan medoxomil | 357 | 11.3K | £478 | +418.2% ▲ |
| Ferrous sulfate | 357 | 11.9K | £399 | -30.6% ▼ |
| Tirzepatide | 355 | 364 | £34.3K | +82.8% ▲ |
| Medroxyprogesterone acetate | 348 | 355 | £1.9K | +188.2% ▲ |
| Cyclizine hydrochloride | 342 | 12.4K | £448 | +112.0% ▲ |
| 335 | 130.2K | £2.1K | +27.0% ▲ | |
| Clobetasone butyrate | 329 | 13.4K | £2.8K | +61.2% ▲ |
| Mesalazine (Systemic) | 326 | 30.1K | £14.2K | +36.1% ▲ |
| Sitagliptin | 322 | 7,840 | £568 | -17.4% ▼ |
| 318 | 40.6K | £1.1K | +15.0% ▲ | |
| 310 | 2,665 | £697 | +48.3% ▲ | |
| Memantine hydrochloride | 308 | 8,245 | £1.5K | -6.8% ▼ |
| Zopiclone | 307 | 5,803 | £243 | -44.6% ▼ |
| Sodium valproate | 306 | 47.9K | £3.6K | -3.8% ▼ |
| Tadalafil | 305 | 4,480 | £2.3K | +79.4% ▲ |
| Fluticasone propionate (Inhalation) | 301 | 323 | £7.7K | -22.2% ▼ |
| Perindopril erbumine | 299 | 7,411 | £629 | -43.7% ▼ |
| Etoricoxib | 299 | 9,296 | £1.9K | +271.1% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 295 | 295 | £13.0K | +76.4% ▲ |
| Glyceryl trinitrate | 294 | 1,233 | £1.1K | +24.3% ▲ |
| Sulfasalazine | 290 | 32.3K | £6.2K | +122.8% ▲ |
| Estriol | 289 | 4,490 | £2.8K | +35.8% ▲ |
| Trimethoprim | 288 | 8,320 | £380 | +40.9% ▲ |
| Sacubitril/valsartan | 286 | 15.3K | £25.0K | +19.4% ▲ |
| Estradiol | 283 | 6,604 | £3.3K | +4.9% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 282 | 18.8K | £1.6K | +24.8% ▲ |
| Azithromycin | 258 | 5,844 | £1.4K | +103.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.